These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 7857099)

  • 21. [Evaluation of long-term administration of oral anti-cancer agent].
    Watanabe H; Sakakibara N
    Gan To Kagaku Ryoho; 1993 Apr; 20(5):637-42. PubMed ID: 8470922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Tissue UFT distribution and histological changes following UFT administration in metastatic liver cancer cases].
    Yoshikawa K; Iwasaki T; Amemiya A; Emoto T; Fujii M; Han N; Itou A; Tsujimura T
    Gan To Kagaku Ryoho; 1990 Jul; 17(7):1333-7. PubMed ID: 2114828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [UFT-E granule compliance in postoperative adjuvant chemotherapy].
    Komoriyama H; Hanai A; Kanasugi K; Hagiwara M; Yamaguchi S
    Gan To Kagaku Ryoho; 1999 Aug; 26(9):1321-7. PubMed ID: 10478186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of food on the oral bioavailability of UFT and leucovorin in cancer patients.
    Damle B; Ravandi F; Kaul S; Sonnichsen D; Ferreira I; Brooks D; Stewart D; Alberts D; Pazdur R
    Clin Cancer Res; 2001 Mar; 7(3):517-23. PubMed ID: 11297242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An anticancer drug sensitivity test to determine the effectiveness of UFT as postoperative adjuvant chemotherapy for patients with stage III colorectal cancer.
    Isogai A; Nagaya M; Matsuoka H; Watanabe T; Tsukikawa S; Kubota S
    Surgery; 2007 Nov; 142(5):741-8. PubMed ID: 17981195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effects of preoperative administration of UFT in gastrointestinal cancer].
    Sato Y; Une Y; Nagabuchi E; Matsuoka S; Kagaya H; Miyata S; Yakura Y; Uchino J
    Gan To Kagaku Ryoho; 1986 Feb; 13(2):337-41. PubMed ID: 3080966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A clinical pharmacokinetic analysis of tegafur-uracil (UFT) plus leucovorin given in a new twice-daily oral administration schedule.
    Etienne-Grimaldi MC; François E; Cardot JM; Renée N; Douillard JY; Gamelin E; Bennouna J; Château Y; Milano G
    Clin Pharmacokinet; 2007; 46(11):953-63. PubMed ID: 17922560
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [UFT concentration in various tissues from cancer patients].
    Kasai Y; Nakanishi Y; Nishi H; Nishindai H; Yoshimoto M; Nakamura T; Hashimoto I; Sawada Y; Mikami J; Bekki E
    Gan To Kagaku Ryoho; 1983 Oct; 10(10):2130-8. PubMed ID: 6414381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase I and pharmacokinetic study of the oral fluoropyrimidine S-1 on a once-daily-for-28-day schedule in patients with advanced malignancies.
    Chu QS; Hammond LA; Schwartz G; Ochoa L; Rha SY; Denis L; Molpus K; Roedig B; Letrent SP; Damle B; DeCillis AP; Rowinsky EK
    Clin Cancer Res; 2004 Aug; 10(15):4913-21. PubMed ID: 15297391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pharmacokinetic study in biochemical modulation therapy of UFT with leucovorin tablet].
    Yamamura T; Oikawa H; Hanai A; Matsuzaki H; Akaishi O; Seo K; Kikuchi K; Ozasa T; Tsukikawa S; Yamaguchi S
    Gan To Kagaku Ryoho; 1995 Feb; 22(2):245-51. PubMed ID: 7857100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [5-FU, FT-207 and uracil concentrations in the serum and tissues of patients with cervical cancer after UFT oral administration].
    Tanimura T; Kaneshige E; Fujiwara K; Kobashi Y; Inoue K; Kono I; Sekiba K
    Gan To Kagaku Ryoho; 1986 Feb; 13(2):349-55. PubMed ID: 3080967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Multicenter cooperative study of pre- and post-operative adjuvant chemotherapy in the treatment of colorectal cancer. North Kyushu Co-operative Study Group for Cancer Chemotherapy].
    Kuroda Y; Arima S; Ohsato K; Ohkuma R; Fukuyama N; Yamanouchi A; Hisatsugu T; Yamamoto H; Nakamura Y; Abe R
    Gan To Kagaku Ryoho; 1992 Oct; 19(12):2025-30. PubMed ID: 1417010
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antitumor effect of UFT against differentiated thyroid cancer].
    Suzumura K; Koike A; Naruse T; Matsumoto K; Nagata H; Kojima T; Kanemitsu T; Katoh K
    Gan To Kagaku Ryoho; 1994 Oct; 21(14):2485-9. PubMed ID: 7944495
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Study of pre-operative chemotherapeutic methods for colonic cancer--the concentration in blood and tissues after pre-operative administration of UFT].
    Sawa H; Fujii M; Sakabe T; Tanaka T
    Gan To Kagaku Ryoho; 1991 Oct; 18(13):2277-81. PubMed ID: 1929448
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Drug concentration in cancerous large bowel tissue and thymidylate synthase inhibition rate after administration of tegafur and UFT].
    Futami K; Arima S; Yoshimura S; Okamoto T; Yamasaki K; Koto T; Yamasaki S; Kawahara K; Ikuno T
    Gan To Kagaku Ryoho; 1991 Feb; 18(2):215-20. PubMed ID: 1992915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [5-FU concentration in tumor tissue and the antitumor effect in patients with gastric cancer after oral administration of UFT].
    Fukunaga H; Katsumi M; Aoki Y; Oka S; Konishi R; Yukawa H; Kawaguchi T; Tamaki Y; Takifuji K
    Gan To Kagaku Ryoho; 1987 Sep; 14(9):2735-9. PubMed ID: 3115184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 5-Ethynyluracil (776C85): effects on the antitumor activity and pharmacokinetics of tegafur, a prodrug of 5-fluorouracil.
    Cao S; Baccanari DP; Joyner SS; Davis ST; Rustum YM; Spector T
    Cancer Res; 1995 Dec; 55(24):6227-30. PubMed ID: 8521418
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [5-FU concentration in tissues of gastric cancer patients with preoperative administration of UFT--especially in comparison with FT-207].
    Takeshita M; Ishikawa H; Seki M; Ikeya T; Miyamoto Y; Izuo M; Tozuka S; Usui R; Kaneko H
    Gan No Rinsho; 1985 Oct; 31(13):1697-703. PubMed ID: 3935831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinico-pharmacological study on UFT enteric-coated granules for gastric cancer patients].
    Takayama S; Aoki T; Hirai K; Fujimori T; Sekine C; Tadaoka N; Nimura H; Tsutsumi J; Kashimura H; Sano Y
    Gan To Kagaku Ryoho; 1993 Mar; 20(4):537-9. PubMed ID: 8452393
    [No Abstract]   [Full Text] [Related]  

  • 40. [5-FU concentration in blood and tissue of patients with primary lung cancer after oral administration of UFT].
    Oiwa T; Saito H
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):525-30. PubMed ID: 3082289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.